ELEVATED PLASMA-LEVELS OF TCF-BETA-1 IN PATIENTS WITH INVASIVE PROSTATE-CANCER

被引:138
作者
IVANOVIC, V [1 ]
MELMAN, A [1 ]
DAVISJOSEPH, B [1 ]
VALCIC, M [1 ]
GELIEBTER, J [1 ]
机构
[1] MONTEFIORE MED CTR,BRONX,NY 10461
关键词
D O I
10.1038/nm0495-282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:282 / 284
页数:3
相关论文
共 15 条
[1]   CLINICAL-EVIDENCE FOR AND IMPLICATIONS OF THE MULTISTEP DEVELOPMENT OF PROSTATE-CANCER [J].
CARTER, HB ;
PIANTADOSI, S ;
ISAACS, JT .
JOURNAL OF UROLOGY, 1990, 143 (04) :742-746
[2]  
DALAL BI, 1993, AM J PATHOL, V143, P381
[3]   EFFECTS OF INTERFERON BETA-SER AND TRANSFORMING GROWTH-FACTOR-BETA ON PROSTATIC CELL-LINES [J].
GOLDSTEIN, D ;
OLEARY, M ;
MITCHEN, J ;
BORDEN, EC ;
WILDING, G .
JOURNAL OF UROLOGY, 1991, 146 (04) :1173-1177
[4]   HUMAN TRANSFORMING GROWTH-FACTOR TYPE-BETA-2 - PRODUCTION BY A PROSTATIC ADENOCARCINOMA CELL-LINE, PURIFICATION, AND INITIAL CHARACTERIZATION [J].
IKEDA, T ;
LIOUBIN, MN ;
MARQUARDT, H .
BIOCHEMISTRY, 1987, 26 (09) :2406-2410
[5]   ELEVATED TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-BETA-3 MESSENGER-RNA LEVELS ARE ASSOCIATED WITH RAS + MYC-INDUCED CARCINOMAS IN RECONSTITUTED MOUSE PROSTATE - EVIDENCE FOR A PARACRINE ROLE DURING PROGRESSION [J].
MERZ, VW ;
MILLER, GJ ;
KREBS, T ;
TIMME, TL ;
KADMON, D ;
PARK, SH ;
EGAWA, S ;
SCARDINO, PT ;
THOMPSON, TC .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (04) :503-513
[6]  
NISHIYA M, 1994, CANCER-AM CANCER SOC, V74, P3002, DOI 10.1002/1097-0142(19941201)74:11<3002::AID-CNCR2820741118>3.0.CO
[7]  
2-G
[8]   MOLECULAR AND CELLULAR-CHANGES ASSOCIATED WITH THE ACQUISITION OF METASTATIC ABILITY BY PROSTATIC-CANCER CELLS [J].
RINKERSCHAEFFER, CW ;
PARTIN, AW ;
ISAACS, WB ;
COFFEY, DS ;
ISAACS, JT .
PROSTATE, 1994, 25 (05) :249-265
[9]   ELEVATED LEVELS OF PLASMA TRANSFORMING GROWTH-FACTOR-BETA IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
SHIRAI, Y ;
KAWATA, S ;
ITO, N ;
TAMURA, S ;
TAKAISHI, K ;
KISO, S ;
TSUSHIMA, H ;
MATSUZAWA, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (07) :676-679
[10]  
SMITH JA, 1993, UROL CLIN N AM, V20, P771